<DOC>
	<DOCNO>NCT01489410</DOCNO>
	<brief_summary>Chemoembolization hepatocellular carcinoma lesion accept frequently use method palliative curative treatment lesion . These attempt make make patient well candidate liver transplant provide palliation condition .</brief_summary>
	<brief_title>Comparing Lipiodol/Ethanol With Drug-eluting Beads ( DEB ) Hepatocellular Carcinoma</brief_title>
	<detailed_description>This randomize prospective study two arm , Drug-Eluting Beads doxorubicin ( DEB ) lipiodol ethanol mixture ( LEM ) , goal show non-inferiority LEM , true facilitate simple alternative DEBs . Patients randomize one arm study remain arm need embolization future . Both mention method ( DEB LEM ) fall within standard care .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Ethiodized Oil</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>ChildPugh class A B Biopsy proven HCC hypervascular mass per European Association Study Liver ( EASL ) criteria Patient candidate surgical resection percutaneous ablation age &gt; 18 year old able consent ChildPugh class C Model EndStage Liver Disease ( MELD ) score &gt; 16 Extrahepatic disease Bilateral main portal vein thrombus Total bilirubin &gt; 2.2 Serum albumin &lt; 2.6 Life expectancy &lt; 2 month Uncorrected INR &gt; 2 Eastern Cooperative Oncology Group ( ECOG ) status &gt; 2 Tumor burden &gt; 50 % liver volume Hepatofugal portal venous flow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>